Live Breaking News & Updates on Intelgenx versafilm
Stay updated with breaking news from Intelgenx versafilm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAINT LAURENT, Quebec, April 05, 2024 -- IntelGenx Corp. today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC , has received a Complete Response...
SAINT LAURENT, Quebec, Sept. 19, 2023 -- IntelGenx Corp. today provided a regulatory update on Buprenorphine Buccal Film, for which an abbreviated new drug application has been filed with the...
IntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal Film streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Opticann completes shipments of CBD filmstrips formulated with Heritage CBD and manufactured using IntelGenx VersaFilm® technologyTORONTO--(BUSINESS WIRE)--Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), is pleased to announce its subsidiary Opticann has signed two supply a...
Heritage Cannabis Reports First Quarter 2021 Financial Results “Heritage” or the “Company”), today announced its financial results as at and for the three months ended January 31, 2021 (“ Q1 2021”). All figures are in Canadian dollars unless otherwise noted. “As we have stated previously, first quarter results do not include the positive impacts of the Premium 5 acquisition given the transaction closed at the end of the quarter, nor does it include results from our initial medical launch which will begin later this month,” stated Clint Sharples, Chief Executive Officer of Heritage. “As we move forward, we expect to see continued acceleration in both our medical and recreational product divisions with the addition of Premium 5 starting to have a material effect in Canada. Additionally, with our imminent launch in the multi-billion dollar U.S. market, and continued growth from our Pura Vida and Purefarma brands we expect to be well positioned to drive further positive results and shareholder value.”